20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alpha Teknova Inc (TKNO) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Hollister, United States with about 158 employees. Its market capitalization is roughly $454 million. In the fiscal year ended 2025-12-31, TKNO reported $41M in revenue and ($17M) in net income.
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Interactive charts & full statements → Open the TKNO valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $43M | $41M | $38M | $37M | $41M | $37M | $31M | $20M |
| Gross Profit | $14M | $13M | $7M | $10M | $17M | $18M | $18M | $9M |
| Gross Margin % | 32.6% | 33.2% | 19.2% | 28.1% | 42.2% | 47.8% | 56.7% | 42.7% |
| Operating Income (EBIT) | ($16M) | ($17M) | ($26M) | ($36M) | ($50M) | ($12M) | $5M | ($2M) |
| Operating Margin % | -37.2% | -41.9% | -69.3% | -96.9% | -119.9% | -32.6% | 14.9% | -9.2% |
| Net Income | ($17M) | ($17M) | ($27M) | ($37M) | ($47M) | ($10M) | $4M | ($1M) |
| Net Margin % | -39.5% | -42.6% | -70.9% | -100.3% | -114.6% | -26.6% | 11.4% | -6.5% |
| EBITDA | ($9M) | ($10M) | ($20M) | ($26M) | ($26M) | ($9M) | $7M | $0M |
| Earnings Per Share (EPS) | $-0.31 | $-0.32 | $-0.57 | $-1.16 | $-1.69 | $-0.35 | $0.90 | $-0.36 |
| Shares Outstanding (M) | 54M | 53M | 47M | 32M | 28M | — | 4M | 4M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $12M | $11M | $10M | $10M | $10M | $10M | $9M | $10M |
| Gross Profit | $5M | $3M | $3M | $3M | $4M | $3M | $2M | $0M |
| Gross Margin % | 40.1% | 31.6% | 32.5% | 30.7% | 38.7% | 30.7% | 23.0% | 0.9% |
| Operating Income (EBIT) | ($3M) | ($4M) | ($5M) | ($4M) | ($3M) | ($5M) | ($6M) | ($7M) |
| Operating Margin % | -23.7% | -38.8% | -46.2% | -38.4% | -32.9% | -50.7% | -60.7% | -77.6% |
| Net Income | ($3M) | ($5M) | ($5M) | ($4M) | ($4M) | ($5M) | ($6M) | ($8M) |
| Net Margin % | -26.0% | -41.1% | -47.7% | -41.0% | -34.7% | -47.4% | -61.7% | -79.0% |
| EBITDA | ($1M) | ($3M) | ($3M) | ($2M) | ($2M) | ($3M) | ($4M) | ($6M) |
| Earnings Per Share (EPS) | $-0.06 | $-0.08 | $-0.09 | $-0.08 | $-0.07 | $-0.09 | $-0.11 | $-0.17 |
| Shares Outstanding (M) | 54M | 54M | 54M | 54M | 53M | 53M | 53M | 45M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($5M) | ($9M) | ($12M) | ($19M) | ($27M) | ($9M) | $3M | $2M |
| Capital Expenditures (CapEx) | $0M | $1M | $1M | $8M | $28M | $20M | $5M | $3M |
| Free Cash Flow (FCF) | ($8M) | ($10M) | ($14M) | ($27M) | ($56M) | ($29M) | ($3M) | $0M |
| FCF Margin % | -18.6% | -24.2% | -35.8% | -72.9% | -134.1% | -78.5% | -9.5% | -2.4% |
| Dividends Paid | — | — | — | $0M | — | — | — | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $0M | ($3M) | $0M | ($2M) | ($2M) | ($4M) | ($1M) | ($2M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $1M | $0M |
| Free Cash Flow (FCF) | ($1M) | ($4M) | ($1M) | ($2M) | ($2M) | ($4M) | ($2M) | ($2M) |
| FCF Margin % | -4.9% | -32.3% | -7.1% | -21.7% | -22.4% | -44.0% | -16.2% | -25.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $96M | $104M | $119M | $129M | $152M | $167M | $63M | $59M |
| Cash & Cash Equivalents | $6M | $6M | $4M | $28M | $42M | $88M | $3M | $4M |
| Total Liabilities | $33M | $35M | $36M | $39M | $52M | $23M | $11M | $46M |
| Total Debt (Short + Long-Term) | $15M | $15M | $15M | $15M | $24M | $12M | $0M | $0M |
| Total Shareholders' Equity | $63M | $69M | $82M | $90M | $100M | $143M | $52M | $13M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TKNO viewer.
About TickerBase · Data methodology & sources · Privacy · Terms